FDA reissues emergency use authorization for COVID-19 treatment
Combination of two human monoclonal antibodies for post-exposure prophylaxis (prevention) of COVID-19 in certain patients
Drugs
The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States
Topic Paragraphs
COVID-19 Updates
Q&A for Consumers | Hand Sanitizers and COVID-19
Learn how the FDA and its partners are addressing the COVID-19 outbreak
Know your treatment options for COVID-19
The FDA approved one drug and many more are being tested in clinical trials
Recent News
CDER expert highlights the evolution of cancer treatments for patients
Dec 3 - 2021 marks the 50th anniversary of the National Cancer Act of 1971
Overview of Over-the-counter (OTC) monograph reform
Dec 2 - Highlights deemed final orders (DFOs) and OTC sunscreen drugs
FDA to host abbreviated clinical investigator training course (CITC)
Nov 9 - Will provide scientific and operational updates from CDER and CBER
Trending Topics
Disposal of Unused Medicines: What You Should Know
The short video shows you how to properly get rid of unused or expired medication
High Blood Pressure–Understanding the Silent Killer
It can lead to many serious problems that’s why it’s important to know your risk factors
BeSafeRx: Your Source for Online Pharmacy Information
Explore resources and tools so you can safely buy prescription medicines online
CENTER FOR DRUG EVALUATION AND RESEARCH
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.